Pimecrolimus 1 percent cream and pulsed dye laser in treatment of a patient with reticular erythematous mucinosis syndrome.
We report on the efficacy of twice daily application of pimecrolimus 1 percent cream in a 48-year-old woman with reticular erythematous mucinosis (REM) syndrome and compare its results with pulsed dye laser (PDL) on the other side of her chest and back. The patient was previously treated by hydroxychloroquine but only a fair response was observed. After application of 5 months of pimecrolimus, the lesions completely resolved and the result was comparable with the other side of her body treated by pulsed dye laser PDL. Topical pimecrolimus and pulsed dye laser appear to be effective and safe treatments for REM.
Mansouri
Parvin
P
Department of dermatology, Tehran University of Medical Sciences, Imam Hospital, Gharib St, Keshavarz Blvd, Tehran, Iran.
Farshi
Susan
S
Nahavandi
Arezo
A
Safaie-Naraghi
Zahra
Z
D000287:Administration, Topical; D001707:Biopsy, Needle; D003131:Combined Modality Therapy; D004890:Erythema / Q000473:pathology* / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D028022:Low-Level Light Therapy / Q000379:methods*; D008875:Middle Aged; D017520:Mucinoses / Q000473:pathology* / Q000628:therapy*; D013577:Syndrome; D016559:Tacrolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
C117268:pimecrolimus; D016559:Tacrolimus